CAS: 1320346-97-1
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | GLPG0187 REF: AN-AG01DDTECAS: 1320346-97-1 | ≥97%(HPLC) | 182.00 €~610.00 € | Wed 08 May 24 |
 | GLPG0187 REF: TM-T4259CAS: 1320346-97-1 | 99.12% | 46.00 €~1,170.00 € | Wed 15 May 24 |
 | GLPG-0187 REF: 3D-VCC34697CAS: 1320346-97-1 | Min. 95% | To inquire | Thu 20 Jun 24 |
Ref: AN-AG01DDTE
| 25mg | 182.00 € | |
| 50mg | 194.00 € | |
| 100mg | 288.00 € | |
| 250mg | 488.00 € |
Estimated delivery in United States, on Wednesday 8 May 2024
GLPG0187
CAS:1320346-97-1
GLPG0187, a broad spectrum integrin receptor antagonist, inhibits αvβ1-integrin (IC50: 1.3 nM).
Formula:
C29H37N7O5S
Purity:
99.12%
Color and Shape:
Solid
Molecular weight:
595.71
Ref: TM-T4259
| 1mg | 46.00 € | |
| 5mg | 101.00 € | |
| 10mg | 149.00 € | |
| 25mg | 245.00 € | |
| 50mg | 362.00 € | |
| 100mg | 538.00 € | |
| 500mg | 1,170.00 € | |
| 1ml*10 (DMSO) | 133.00 € |
Estimated delivery in United States, on Wednesday 15 May 2024
GLPG-0187
CAS:1320346-97-1
GLPG-0187 is an anti-cancer drug that inhibits the proliferation of cancer cells by inducing apoptosis. …
Formula:
C29H37N7O5S
Purity:
Min. 95%
Molecular weight:
595.71 g/mol
Ref: 3D-VCC34697
| 1mg | To inquire | |
| 5mg | To inquire | |
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire |
Estimated delivery in United States, on Thursday 20 Jun 2024
